Please find attached Outcome of Board Meeting held on 31.07.2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunshield Chemicals reported strong Q1 FY26 results with revenue from operations rising ~46% YoY to Rs. 11,388 lakhs (vs Rs. 7,796 lakhs in Q1 FY25), driven by higher raw material costs and volume growth. Profit after tax surged ~70% YoY to Rs. 682 lakhs (vs Rs. 401 lakhs), with EPS of Rs. 9.28 vs Rs. 5.45. The Board approved a fresh Rights Issue of up to Rs. 150 crores to eligible shareholders under SEBI's amended Rights Issue Regulations, withdrawing the earlier Draft Letter of Offer filed in September 2024. The company has already spent Rs. 71.33 lakhs on the issue, sitting in prepaid expenses. The Audit, Nomination & Remuneration, and Stakeholders Relationship Committees were reconstituted effective October 21, 2025. Auditors CNK & Associates LLP issued an unmodified (clean) review report.
Strong operational performance with significant revenue and profit growth is positive for shareholders. However, the Rs. 150 crore Rights Issue will dilute existing shareholders depending on the issue price and entitlement ratio; terms are yet to be decided. Near-term stock price may react to both the strong results and the dilution overhang from the upcoming rights issue.